UBS upgraded Option Care Health from Neutral to Buy and set a new price target of $40.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/1/2026 | $22.00 | Buy → Neutral | BofA Securities |
| 12/11/2025 | $40.00 | Overweight | Stephens |
| 10/2/2025 | $30.00 | Hold | TD Cowen |
| 4/30/2025 | $40.00 | Neutral → Buy | UBS |
| 1/23/2025 | $26.00 → $35.00 | Hold → Buy | Jefferies |
| 1/13/2025 | $26.00 → $33.00 | Neutral → Buy | BofA Securities |
| 12/5/2024 | $26.00 | Neutral | UBS |
| 11/4/2024 | $27.00 | Buy → Neutral | Goldman |
4 - Option Care Health, Inc. (0001014739) (Issuer)
4 - Option Care Health, Inc. (0001014739) (Issuer)
4 - Option Care Health, Inc. (0001014739) (Issuer)
4 - Option Care Health, Inc. (0001014739) (Issuer)
4 - Option Care Health, Inc. (0001014739) (Issuer)
4 - Option Care Health, Inc. (0001014739) (Issuer)
BofA Securities downgraded Option Care Health from Buy to Neutral and set a new price target of $22.00
Stephens initiated coverage of Option Care Health with a rating of Overweight and set a new price target of $40.00
TD Cowen initiated coverage of Option Care Health with a rating of Hold and set a new price target of $30.00
8-K - Option Care Health, Inc. (0001014739) (Filer)
8-K - Option Care Health, Inc. (0001014739) (Filer)
SCHEDULE 13G/A - Option Care Health, Inc. (0001014739) (Subject)
BANNOCKBURN, Ill., June 04, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced the appointment of Robert Okunski as Vice President, Investor Relations effective May 26, 2026. In this role, Okunski will lead the Company's investor relations strategy and serve as the primary liaison between Option Care Health and the investment community. He will be responsible for communicating the Company's business strategy, financial performance, capital allocation priorities and long-term growth opportunities to investors, analysts and other key stakeholders. "Bob brings more than two decade
BANNOCKBURN, Ill., June 01, 2026 (GLOBE NEWSWIRE) -- Option Care Health is proud to announce it has been ranked No. 15 on the World's Most Impactful Companies 2026 list, a global recognition of organizations delivering measurable positive impact across society, the environment, and the economy. This recognition is presented by TIME and Statista, global leaders in data analysis and industry benchmarking, and it can now be viewed on time.com. Being named to the World's Most Impactful Companies 2026 list signifies that Option Care Health stands among a select group of organizations driving meaningful change through their core business activities. Unlike perception-based assessments or self-r
BANNOCKBURN, Ill., May 04, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, will participate in the Bank of America Health Care Conference, being held in Las Vegas, on Tuesday, May 12, 2026, including a fireside chat at 10:40am PT/1:40pm ET. The webcast will be available online at https://investors.optioncarehealth.com. About Option Care Health Option Care Health is the nation's largest independent provider of home and alternate site infusion services. With over 8,000 team members including more than 5,000 clinicians, we work compassionately to elevate standards
SC 13G - Option Care Health, Inc. (0001014739) (Subject)
SC 13G/A - Option Care Health, Inc. (0001014739) (Subject)
SC 13G/A - Option Care Health, Inc. (0001014739) (Subject)
BANNOCKBURN, Ill., April 30, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter ended March 31, 2026. First Quarter 2026 Financial Highlights(year-over-year comparisons unless otherwise noted) Net revenue of $1,350.7 million, up 1.3%GAAP Net income of $45.3 million, down 3.0%GAAP diluted earnings per share of $0.29, up 3.6%Adjusted EBITDA of $104.8 million, down 6.3%Adjusted diluted earnings per share of $0.40, flat to the first quarter of 2025Cash used in operating activities of $12.1 million
BANNOCKBURN, Ill., April 08, 2026 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its first quarter ended March 31, 2026 on Thursday, April 30, 2026 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call DetailsParticipants can pre-register for the conference call at the following link: https://register-conf.media-server.com/register/BIbd179b6862b941cc9436001259706de3. The call can also be accessed via a li
BANNOCKBURN, Ill., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights (year-over-year comparisons unless otherwise noted) Net revenue of $1,465.4 million, up 8.8%Net income of $58.5 million, down 2.7%GAAP diluted earnings per share of $0.37, up 5.7%Adjusted EBITDA of $126.0 million, up 3.7%Adjusted diluted earnings per share of $0.46, up 4.5%Repurchased $95 million of stock in the quarter Full Year 2025
BANNOCKBURN, Ill., June 04, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced the appointment of Robert Okunski as Vice President, Investor Relations effective May 26, 2026. In this role, Okunski will lead the Company's investor relations strategy and serve as the primary liaison between Option Care Health and the investment community. He will be responsible for communicating the Company's business strategy, financial performance, capital allocation priorities and long-term growth opportunities to investors, analysts and other key stakeholders. "Bob brings more than two decade
BANNOCKBURN, Ill., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced the appointment of Meenal Sethna as Executive Vice President and Chief Financial Officer, effective October 1, 2025. Sethna will succeed Mike Shapiro, who has decided to step down as CFO effective September 30, 2025, following a decade of service to the Company. At the time of the transition, Shapiro will remain with the Company as a Strategic Advisor through at least the first quarter of 2026 to continue to help advance the Company's strategy and ensure a smooth
Marks major milestone with completion of enrollment in pivotal Phase 3 NEAT clinical trial evaluating lead asset, eDSP, for the treatment of A-T; topline results expected in first quarter of 2026 Closed financing priced at a premium bringing existing cash position to approximately $35 million; expected to provide runway through Phase 3 topline results and into at least second quarter of 2026 Entered into strategic relationship with Option Care Health to support commercial launch of eDSP in the U.S. Quince Therapeutics, Inc. (NASDAQ:QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, today provided an